Genefron Ltd. is active in the field of genomic based personal medicine, using personal gene expression (PGE) signatures derived by bioinformatics for in-vitro companion diagnostics.
Our promise, forever to be kept, is to center the patient, focus on patient needs, reduce patient suffer and direct the ultimate treatment for the fastest recovery possible.
Genefron Ltd., was established in 2011 to develop and manufacture unique diagnostic tests confronting the challenge of personalizing the medical treatments. The company is privately held by the founders and private investors.
Genefron is specializing in genomic based personal medicine, using gene expression signatures derived by cutting edge bioinformatics developments, for in vitro personalized companion diagnostics.